Advocacy in Hemophilia, Online, November 9th, 2021

The global hemophilia ecosystem is rapidly evolving. With an explosion in innovation, there are more treatments, diagnostics and tools than ever before. At the same time, achieving sustainable access to these innovations is a significant challenge, exacerbated by an array of geographic and socio-economic factors.

To share new ideas and best practices to help advance higher standards of care for people with hemophilia across the globe, you’re invited to join this virtual event Advocacy in Hemophilia, on Tuesday 9 November 2021, at 9:30am ET / 3:30pm CET.

Reuters Events, in partnership with Sanofi Genzyme, is proud to bring together leaders of the global hemophilia and rare disease advocacy communities, hematologists, policymakers, patients, payers and regulators, to join these important conversations and help advance positive change for people with hemophilia around the world.

Join us to collectively explore sustainable solutions for accessing treatment, care and support. Register for this FREE event here.

Speakers: Cesar Garrido, President, The World Federation of Hemophilia, Amanda Bok, CEO, European Haemophilia Consortium , Chris Bombardier, Executive Director, Save One Life, Durhane Wong-Rieger, CEO and President, Canadian Organization of Rare Disorders (and Chair, Rare Diseases International)